Role of Kinins in Inflammatory Responses: Prospects for Drug Therapy

Clinical Immunotherapeutics

Volumn 3, Issue 5, 1995, Pages 352-361

  Rodell, Timothy C ^a   Naidoo, Yugen ^b   Bhoola, Kanti D ^b  

^a Departments of New Leads Chemistry and Pharmacology   (United States)

^b UNIVERSITY OF NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ DERIVATIVE; DELTIBANT; DEXTRO ARGINYLBRADYKININ[3 HYDROXYPROLINE 7 DEXTRO PHENYLALANINE]; ICATIBANT; KALLIDIN; KININ; NPC 17761; UNCLASSIFIED DRUG;

ARTHRITIS; ASTHMA; BIOSYNTHESIS; EDEMA; HUMAN; INFLAMMATION; KIDNEY GRAFT REJECTION; PRIORITY JOURNAL; REVIEW; RHINITIS;

EID: 0028919888     PISSN: 11727039     EISSN: 1179190X     Source Type: Journal    
DOI: 10.1007/BF03259501     Document Type: Review

References (39)

1. Bioregulation of kinins: kallikreins, kininogens, and kininases
2. Apnea, bradycardia, hypotension and muscular contraction induced by intracarotid injection of bradykinin
3. Identification of immunoreactive tissue kallikrein in human polymorphonuclear leucocytes
4. Immunovisualization of high (HK) and low (LK) molecular weight kininogens on isolated human neutrophils
5. Assembly of contact phase factors on the surface of the human neutrophil membrane
6. Identification of immunoreactive tissue kallikrein in human ductal breast carcinomas
7. 2 kinin receptor
8. Molecular biology of bradykinin receptors
9. Receptors for bradykinin and related kinins: a critical analysis
10. 8]-bradykinin, a potent antagonist of smooth muscle BK2 receptors and BK3 receptors
11. Bradykinin competitive antagonists: design and activities
12. 7]-bradykinin, does not affect the response to nasal provocation with bradykinin
13. New, long-acting, potent and long acting bradykinin-antagonist: in vitro studies
14. New, long-acting, potent bradykinin antagonist
15. A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccininimidoalkine peptide dimers
16. Bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers
17. Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides
18. 2 receptor antagonists
19. 2 antagonist activity
20. CP-0127, a novel potent bradykinin antagonist, increases survival in rat and rabbit models of endotoxin shock
21. Beneficial actions of CP-0127, a novel bradykinin receptor antagonist, in murine traumatic shock
22. Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist Hoe 140
23. Definitions for sepsis and organ failure and guidelines for the use of innovative therapeutics in sepsis
24. The systemic inflammatory response syndrome: does the new name mean new therapies?
25. Release of the kinin moiety from kininogen on the other surface of the circulating neutrophil in patients with sepsis: peptides and their antagonists in tissue injury
26. Preclinical and clinical studies with CP-0127, a bradykinin antagonist
27. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen
28. Kinin receptor antagonists: unique probes in basic and clinical research
29. Localization of immunoreactive tissue kallikrein in the seromucous glands of the human and guinea-pig respiratory tree
30. Role of kinins in airway diseases
31. The potential role of bradykinin antagonists in the treatment of asthma
32. Kinins - key mediators in inflammatory arthritis?
33. Localization of immunoreactive kininogen and tissue kallikrein in the human nephron
34. Cellular localization of atrial natriuretic peptide and tissue kallikrein in the human hypothalamus
35. 2 receptor stimulation and is potentiated by concomitantly released prostaglandins
36. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 1: cerebral exposure to bradykinin and plasma
37. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 2: studies on kinin formation in focal and perifocal brain tissue
38. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 3: inhibition of the kallikrein-kinin system in traumatic brain swelling